ArticleJournal of gastroenterology2014

Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis.

Hitoshi Yoshiji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.